Company intelligence / Profile preview

Lakeside Holding

Itasca, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Lakeside Holding, via recent acquisition of Hupan Pharmaceutical, delivers pharmaceutical distribution and logistics solutions in China, specializing in temperature-controlled transport for essential medicines (including sodium bicarbonate, glucose, peptide hormones) serviced under contracts with Sinopharm and other major pharmaceutical firms. Recent clinical results not applicable as the company does not conduct clinical trials but provides logistics for critical medicines

Modalities: Small moleculePeptidesBiologic
Industry: Contract Research Organization

Partnerships

Sinopharm Group Hubei Co., Ltd.Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun Pharmaceutical)Sichuan Huiyu Pharmaceutical Co., Ltd.

Beyond the preview

Go deeper on Lakeside Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lakeside Holding.

Explore the full profile